Skip to main content
Clinical Trials/NCT02275182
NCT02275182CompletedPhase 4

Impact of Dexmedetomidine Sedation on the Post-Operative Cognition Dysfunction--a Multiple Center,Randomized, Controlled,Double Blinded Clinical Trial.

The First Affiliated Hospital of Anhui Medical University13 sites in 1 country864 target enrollmentStarted: October 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
864
Locations
13
Primary Endpoint
The change of incidence of postoperative cognition dysfunction

Study Overview

Brief Summary

Post-Operative Cognition Dysfunction (POCD) is a common complication after surgery, POCD can lead to a reduced ability and seriously affect the quality of life of patients, increase personal and social burden, POCD may also increase mortality.POCD can occur at any age, but the long-term, affect the daily lives of POCD in elderly patients over 60 years of age are more prone. Age is a risk factor for advanced or long-term POCD. POCD determined by preoperative cognitive function and psychological scales postoperative assessment, the main recommendation of the agreed test methods include, Rey auditory verbal test, the connection test, digit span test. In this study, preoperative mini-mental state examination (MMSE) screening, comprehensive neurological function during hospitalization for memory, attention, executive function and exercise capacity test, and telephone follow-up after discharge Scale Revised (TICS-M) test.

Few study showed that dexmedetomidine may improve cognitive function in young patients others show that dexmedetomidine did not reduce POCD incidence after 24 hours of surgery. These results conflict and it is necessary to carry out large-scale, multi-center, randomized, controlled clinical study to determine whether dexmedetomidine reduce the POCD incidence or not for elderly patients.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
65 Years to 90 Years (Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Written informed consent
  • Selective surgery and general anesthesia patients(abdomen,orthopedics and urology surgery is preferred);
  • Age 65-90 yrs;
  • Anesthesia Society of American (ASA) Scale II~III;
  • Anticipated surgery time 2-6 hrs; -

Exclusion Criteria

  • Dementia patients(Mini-mental state examination< 20)
  • Factors existed that affect cognition assessment such as language,visual,and auditory dysfunction;
  • Unstable metal status and mental disease;
  • The cognitive function examination in 3-6 months is not anticipated to be completed
  • II-III Atrioventricular block;
  • Heat rate < 50 beats/minutes;
  • Parkinson's Disease;
  • May occur or have occurred the difficult airway or anticipated delayed extubation
  • Sure or suspected abuse of analgesic and sedation drug;
  • Allergic to the trial drug and other anesthesia drug contraindication; -

Arms & Interventions

Dexmedetomidine

Experimental

0.5μg/kg Dexmedetomidine as initial loading dose is given for 15 minutes before induction of anesthesia, followed by a maintenance infusion of 0.4μg/kg/h and stopped 30 minutes before the surgery over.

Intervention: Dexmedetomidine (Drug)

Controlled

Placebo Comparator

0.5μg/kg Saline as initial loading dose is given for 15 minutes before induction of anesthesia, followed by a maintenance infusion of 0.4μg/kg/h and stopped 30 minutes before the surgery over.

Intervention: Saline (Drug)

Outcomes

Primary Outcomes

The change of incidence of postoperative cognition dysfunction

Time Frame: 1 day Before surgery,the 3rd,7th day after the surgery.

1. The neuropsychological tests performed at the day before the surgery, the 3rd and 7th day after the surgery respectively. 2. A test environment to keep quiet, well-lit, non-interference, all the test items should be completed within 30 min. 3. Normal population (65 to 90 years age-matched 400 non-surgery people) should perform neuropsychological tests in the same time interval, then calculate the score difference(ΔXc), and the standard deviation(SD) of the difference. 4. Calculate the difference(ΔX) between the score obtained before surgery and 3 or 7 days after the surgery (there are both positive and negative, we use the absolute value), with this difference( ΔX) divided by the standard deviation(SD)of the difference of the normal population, that is ΔX / SD and it is the Z score. 5. POCD Diagnosis: if a patient has two or more than two of the absolute value of Z scores ≥1.96, the POCD is exist.

The change of incidence of postoperative delirium

Time Frame: The first, second and third day after the surgery.

Through CAM-ICU to assess the incidence of the postoperative delirium.

The change of Neuropsychological status

Time Frame: the 3rd,6th month after the surgery

Through the Telephone Interview for Cognitive Status-Modified(TICS-m) to follow up.

Secondary Outcomes

  • The occurrence of cardiovascular events.(from begging of the anesthesia to the time the patients discharge, up to 1 month.)
  • The incidence of any adverse or severe adverse events.(From the beginning of the admitted to 6 month after the surgery, up to 6 month.)
  • the variation of pulse oxygen saturation.(From the beginning to the end of anesthesia,up to 6 hours.)
  • The variation of heart rate.(From the beginning to the end of anesthesia,up to 6 hours.)
  • The variation of blood pressure.(From the beginning to the end of anesthesia,up to 6 hours.)
  • The monitor of depth of anesthesia.(From the beginning to the end of anesthesia,up to 6 hours.)
  • The serum concentrations of BDNF(From the baseline to the 3-day,7-day and 1-month.)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Xinqi Cheng

Anesthesia Department

The First Affiliated Hospital of Anhui Medical University

Study Sites (13)

Loading locations...

Similar Trials

Impact of Dexmedetomidine on the... | Clinical Trial